Wilmington Pharmaceuticals
Wilmington
About Wilmington Pharmaceuticals
At Wilmington Pharmaceuticals, they develop and out-license patient-friendly, fast-dissolving formulations for established medicines. They achieve FDA approval and rapid commercialization for their licensing partners, minimizing regulatory risk while maximizing economic opportunity. Their points of differentiation provide you with an ideal development partner.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2006)
- Website: wilmingtonpharma.com
- Phone: 910-509-0097
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/wilmington-pharmaceuticals-3151752 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.